Prime Medicine, Inc.PRMENASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-6.33%
↑ 81% vs avg
Percentile
P48
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-32.93%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -6.33% |
| Q3 2025 | 15.39% |
| Q2 2025 | 15.24% |
| Q1 2025 | -400.75% |
| Q4 2024 | 162.69% |
| Q3 2024 | 43.04% |
| Q2 2024 | 32.81% |
| Q1 2024 | -54.36% |
| Q4 2023 | -12.00% |
| Q3 2023 | 4.05% |
| Q2 2023 | 1.78% |
| Q1 2023 | -35.32% |
| Q4 2022 | -2.04% |
| Q3 2022 | -48.83% |
| Q2 2022 | 60.19% |
| Q1 2022 | -285.17% |
| Q4 2021 | -37.28% |
| Q3 2021 | -49.81% |
| Q2 2021 | -31.47% |
| Q1 2021 | -96.18% |
| Q4 2020 | 0.00% |
| Q4 2019 | 0.00% |